Literature DB >> 16799798

Characteristics of HIV-infected children recently diagnosed in Paris, France.

Eugenia Macassa1, Marianne Burgard, Florence Veber, Capucine Picard, Bénédicte Neven, Nizar Malhaoui, Christine Rouzioux, Stéphane Blanche.   

Abstract

Pediatric HIV-1 infections are still being diagnosed in France, despite the efficacy of prophylactic treatment to prevent mother-to-child transmission. To describe the characteristics and mode of infection of these children, we retrospectively analysed data of 59 children diagnosed with the HIV-1 infection between January 2000 and June 2005 in a Parisian university hospital. Twenty of these children had been born in France, and none had received appropriate prophylaxis (insufficient, not taken or given too late). Six received no preventive treatment due to failures in screening: three mothers were HIV-seronegative at the start of pregnancy and no test was carried out for the other three. At diagnosis, four had a severe immune deficiency (CD4 cells <15%). The 39 children born abroad were diagnosed at a median age of 3 years (range: 3 months-16 years), sometimes several years after their arrival in France. The clinical, virological and immunological status of these children was poorer than that of the children born in France: 18 had less than 15% CD4 cells. In contrast, the response to treatment of the children born in France was not as good as that of the children born abroad. The HIV-1 screening and prevention programme for pregnant women could be improved. Some children infected following the failure of prevention are at high risk of subsequent treatment failure. HIV-1 infection should be taken into consideration in children born in countries with a high prevalence of HIV, even if they have been living in France for several years and present no symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16799798     DOI: 10.1007/s00431-006-0091-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

Authors: 
Journal:  HIV Clin Trials       Date:  2001 Jan-Feb

2.  Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

Authors:  Jesús Castilla; Jorge Del Romero; Victoria Hernando; Beatriz Marincovich; Soledad García; Carmen Rodríguez
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

Review 3.  Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions.

Authors:  Elaine J Abrams
Journal:  AIDS Rev       Date:  2004 Jul-Sep       Impact factor: 2.500

4.  Disparities in prenatal HIV testing: evidence for improving implementation of CDC screening guidelines.

Authors:  Deborah N Pearlman; Abigail R Averbach; Sally Zierler; Kevin Cranston
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 5.  Management of antiretroviral therapy in neonates, children, and adolescents.

Authors:  Michael Neely; Andrea Kovacs
Journal:  Curr HIV/AIDS Rep       Date:  2004-06       Impact factor: 5.071

6.  Universal prenatal HIV screening: patient attitudes and perceptions.

Authors:  Kristin A Kelly; Chase H Harrison
Journal:  Women Health       Date:  2004

7.  Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Authors:  Ellen R Cooper; Manhattan Charurat; Lynne Mofenson; I Celine Hanson; Jane Pitt; Clemente Diaz; Karen Hayani; Edward Handelsman; Vincent Smeriglio; Rodney Hoff; William Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

8.  Protease inhibitor use in 233 pregnancies.

Authors:  Anne B Morris; Ana Rua Dobles; Susan Cu-Uvin; Carmen Zorrilla; Jean Anderson; Joseph I Harwell; Jean Keller; Jane Garb
Journal:  J Acquir Immune Defic Syndr       Date:  2005-09-01       Impact factor: 3.731

9.  Evaluation and treatment of the human immunodeficiency virus-1--exposed infant.

Authors:  Susan M King
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

10.  Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort.

Authors:  Marie Jeanne Mayaux; Jean Paul Teglas; Stephane Blanche
Journal:  J Acquir Immune Defic Syndr       Date:  2003-11-01       Impact factor: 3.731

View more
  5 in total

1.  Country of Birth of Children With Diagnosed HIV Infection in the United States, 2008-2014.

Authors:  Steven R Nesheim; Laurie Linley; Kristen M Gray; Tianchi Zhang; Jing Shi; Margaret A Lampe; Lauren F FitzHarris
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

2.  Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.

Authors:  Eliane Rohner; Kurt Schmidlin; Marcel Zwahlen; Rana Chakraborty; Gary Clifford; Niels Obel; Sophie Grabar; Annelies Verbon; Antoni Noguera-Julian; Intira Jeannie Collins; Pablo Rojo; Norbert Brockmeyer; Maria Campbell; Geneviève Chêne; Hans Prozesky; Brian Eley; D Cristina Stefan; Alan Davidson; Cleophas Chimbetete; Shobna Sawry; Mary-Ann Davies; Azar Kariminia; Ung Vibol; Annette Sohn; Matthias Egger; Julia Bohlius
Journal:  Clin Infect Dis       Date:  2016-08-30       Impact factor: 9.079

3.  Treatment of pediatric HIV infection.

Authors:  Elisa A d'Oulx; Elena Chiappini; Maurizio de Martino; Pier-Angelo Tovo
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

4.  A three-source capture-recapture estimate of the number of new HIV diagnoses in children in France from 2003-2006 with multiple imputation of a variable of heterogeneous catchability.

Authors:  Vanina Héraud-Bousquet; Florence Lot; Maxime Esvan; Françoise Cazein; Corinne Laurent; Josiane Warszawski; Anne Gallay
Journal:  BMC Infect Dis       Date:  2012-10-10       Impact factor: 3.090

5.  Resilience and Life Expectations of Perinatally HIV-1 Infected Adolescents in France.

Authors:  Isabelle Funck-Brentano; Lambert Assoumou; Florence Veber; Despina Moshous; Pierre Frange; Stéphane Blanche
Journal:  Open AIDS J       Date:  2016-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.